tag:blogger.com,1999:blog-36768584.post2824641410778611455..comments2024-03-03T18:49:34.382-05:00Comments on Omics! Omics!: A Lazy Look at The Field of Sequencing StartupsKeith Robisonhttp://www.blogger.com/profile/04765318239070312590noreply@blogger.comBlogger5125tag:blogger.com,1999:blog-36768584.post-56094292754724389172020-03-25T10:14:48.560-04:002020-03-25T10:14:48.560-04:00To know more about the startups and latest genetic...To know more about the startups and latest genetic information. Please look onto the link below.<br /><br />https://westonconferences.com/conferences_view/conferences_download_brochure/geneticsandgenomics2020Anonymoushttps://www.blogger.com/profile/07251505634500996869noreply@blogger.comtag:blogger.com,1999:blog-36768584.post-68497318551360579462020-02-26T13:08:34.496-05:002020-02-26T13:08:34.496-05:00A great post Keith. I hope you're enjoying AGB...A great post Keith. I hope you're enjoying AGBT and the 20 year anniversary parties (WIWT)?<br /><br />Considering that most of the cash being pumped into these companies is coming off the back of Solexa/Illumina's successes and that the original GA was launched almost 15 years ago, do you see any slowdown in investment and spinout of new tech? Has it got harder? Will it ever?<br /><br />Lastly, at AGBT in 2014 an investor spoke to me about my April fools post on the Norfolk Nanopore company - they suggested that with a little more "work" I could have raised a few millions; I am sure between the two of us we can come up with something worth spinning out!James@cancerhttps://www.blogger.com/profile/02825715598810395734noreply@blogger.comtag:blogger.com,1999:blog-36768584.post-38665813435973741672020-02-23T03:50:40.191-05:002020-02-23T03:50:40.191-05:00My prediction is that none of the "year or so...My prediction is that none of the "year or so out" companies 3ill have a product out within an year. Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36768584.post-70054026547422075802020-02-21T09:09:58.645-05:002020-02-21T09:09:58.645-05:00Like you, the clues I use for the same type of eva...Like you, the clues I use for the same type of evaluation are:<br />1) Do they have a commercial person on their leadership team?<br />2) Are they hiring commercial and operations people?<br />3) What is their funding history? Launching a new sequencer is difficult if you haven't raised >$100M (probably more like $200M).<br />4) Any recent news/events? Stratos has a nice shiny website but they haven't made blog or news updates in years.<br /><br />I suspect that most of your "year out" companies are either more than a year out or struggling. I would move the "year out" companies to "patience please" and move OmniOme to 1-1.5 years out.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36768584.post-29108982089405980992020-02-21T01:43:35.411-05:002020-02-21T01:43:35.411-05:00Excellent summary - and very educational for someo...Excellent summary - and very educational for someone like myself who is not from the field. A couple months ago I would have stated with utter confidence that nobody is dreaming of launching new sequencers with Illumina and MGI out there. Shows again that one should be careful making statements about things one knows nothing about... But what I'm missing in your post is Genapsys. You mention them at the beginning as a bad example but now they really seem to be ready to go to the market. At least we had a dummy machine from them last week for a show we did in Switzerland. Feedback we received was somewhat mixed and I was hoping you'd give us your thoughts on that one.Danilohttps://www.blogger.com/profile/05211956821896763697noreply@blogger.com